chitosan has been researched along with Insulin Sensitivity in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 9 (56.25) | 2.80 |
| Authors | Studies |
|---|---|
| Tao, W; Wang, G; Wei, J | 1 |
| Chiang, MT; Liu, SH; Tzeng, HP | 1 |
| Li, Z; Mei, J; Wang, Y; Wu, X; Yang, L; Zheng, G | 1 |
| Li, Z; Mei, J; Wang, Y; Yang, L; Zheng, G | 1 |
| Al-Okbi, SY; Ali, O; Aly, AS; Elbakry, HFH; Esmail, RSH; Refaat, D | 1 |
| Banerjee, A; Sharma, D; Singh, J; Trivedi, R | 1 |
| He, N; Li, S; Lv, Z; Wang, S; Zhao, W | 1 |
| El-Shetry, ES; Hamed Arisha, A; Khater, SI; Metwally, MMM; Mohamed, AA; Mostafa-Hedeab, G | 1 |
| Arora, S; Banerjee, A; Sharma, D; Singh, J | 1 |
| Han, L; Hong, A; Li, YW; Ma, M; Ma, Y; Wan, DC; Wang, DH; Xiao, X; Zhao, SJ | 1 |
| Guo, Y; Jie, X; Liu, Y; Wang, J; Xue, C; Zhang, X | 1 |
| Jena, PK; Prajapati, B; Rajput, P; Seshadri, S | 1 |
| González-Ortiz, M; Hernández-González, SO; Martínez-Abundis, E; Robles-Cervantes, JA | 1 |
| Liu, X; Shen, J; Song, T; Sun, Z; Wang, Q; Yang, F; Zeng, A | 1 |
| Liu, X; Liu, Y; Shen, J; Sun, Z; Wu, B; Zhi, X | 1 |
| Cheng, RS; Chiang, MT; Hsieh, YL; Yao, HT | 1 |
2 review(s) available for chitosan and Insulin Sensitivity
| Article | Year |
|---|---|
The Role of Chitosan Oligosaccharide in Metabolic Syndrome: A Review of Possible Mechanisms.
Topics: Anticholesteremic Agents; Aquatic Organisms; Chitosan; Humans; Insulin Resistance; Metabolic Syndrome; Obesity; Oligosaccharides | 2021 |
Antidiabetic Properties of Chitosan and Its Derivatives.
Topics: Animals; Blood Glucose; Chitosan; Diabetes Mellitus, Experimental; Gluconeogenesis; Glucose; Hypoglycemic Agents; Insulin Resistance; Liver; Rats | 2022 |
1 trial(s) available for chitosan and Insulin Sensitivity
| Article | Year |
|---|---|
Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects.
Topics: Adult; Body Mass Index; Body Weight; Chitosan; Double-Blind Method; Female; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Triglycerides; Waist Circumference | 2010 |
13 other study(ies) available for chitosan and Insulin Sensitivity
| Article | Year |
|---|---|
Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Blood-Brain Barrier; Chitosan; Gastrointestinal Microbiome; Insulin Resistance; Mice; Nanoparticles; Peptides; Resveratrol | 2023 |
Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Chitosan; Cognitive Dysfunction; Insulin Resistance; Lipopolysaccharides; Mice; Resveratrol; Selenium; tau Proteins | 2023 |
Management of metabolic syndrome by nutraceuticals prepared from chitosan and ferulic acid with or without beta-sitosterol and their nanoforms.
Topics: Animals; Atorvastatin; Chitosan; Diet, High-Fat; Dietary Supplements; Fructose; Insulin Resistance; Metabolic Syndrome; Rats | 2023 |
Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy.
Topics: 3T3-L1 Cells; Adiponectin; Animals; Chitosan; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Genetic Therapy; Insulin Resistance; Male; Mice; Nanoparticles; Obesity; Oleic Acid; Peptides; Plasmids; Rats, Wistar | 2020 |
Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in high-fat diet (HFD)-fed mice.
Topics: Animals; Bacteria; Chitosan; Diet, High-Fat; Gastrointestinal Microbiome; Humans; Insulin Resistance; Intestines; Male; Mice; Mice, Inbred C57BL; Molecular Weight; Obesity; Oligosaccharides | 2020 |
Chitosan-stabilized selenium nanoparticles alleviate cardio-hepatic damage in type 2 diabetes mellitus model via regulation of caspase, Bax/Bcl-2, and Fas/FasL-pathway.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Blood Glucose; Caspases; Chitosan; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Fas Ligand Protein; fas Receptor; Heart Diseases; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Diseases; Male; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Selenium; Signal Transduction; Streptozocin | 2021 |
Improved insulin sensitivity in obese-diabetic mice via chitosan Nanomicelles mediated silencing of pro-inflammatory Adipocytokines.
Topics: Adipocytes; Adipokines; Adiponectin; Adipose Tissue; Animals; Biocompatible Materials; Chitosan; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Inflammation Mediators; Insulin; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Micelles; Nanoparticles; Obesity; RAW 264.7 Cells; RNA Interference; Tumor Necrosis Factor-alpha | 2021 |
A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.
Topics: Animals; Blood Glucose; Cell Proliferation; Chitosan; Diabetes Mellitus, Type 2; Drug Liberation; Exenatide; Fasting; Glucose; Half-Life; Hydrogen Peroxide; Insulin; Insulin Resistance; Male; Mice; Nanoparticles; Peptides; Reactive Oxygen Species; Receptor, Insulin; Receptors, Vasoactive Intestinal Peptide, Type II; RNA, Messenger; Selenium; Venoms | 2017 |
Green Synthesis of Oxovanadium(IV)/chitosan Nanocomposites and Its Ameliorative Effect on Hyperglycemia, Insulin Resistance, and Oxidative Stress.
Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Stability; Glucose Tolerance Test; Green Chemistry Technology; Hyperglycemia; Insulin Resistance; Liver; Male; Mice, Inbred C57BL; Nanocomposites; Oxidative Stress; Vanadates | 2016 |
Investigation of Chitosan for Prevention of Diabetic Progression Through Gut Microbiota Alteration in Sugar Rich Diet Induced Diabetic Rats.
Topics: Animal Feed; Animals; Carbohydrates; Chitosan; Diabetes Mellitus, Experimental; Diet; Disease Progression; Gastrointestinal Microbiome; Inflammation; Insulin; Insulin Resistance; Male; Rats; Rats, Wistar; Toll-Like Receptors | 2015 |
Therapeutic effect of carboxymethylated and quanternized chitosan on insulin resistance in high-fat-diet-induced rats and 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Adiponectin; Animals; Anti-Obesity Agents; Chitosan; Diet, High-Fat; Disease Models, Animal; Insulin Resistance; Leptin; Male; Mice; Obesity; PPAR gamma; Random Allocation; Rats, Wistar; Resistin; RNA, Messenger | 2012 |
Effect of chitosan, O-carboxymethyl chitosan, and N-[(2-hydroxy-3-N,N-dimethylhexadecyl ammonium)propyl] chitosan chloride on overweight and insulin resistance in a murine diet-induced obesity.
Topics: Animals; Blood Glucose; Chitosan; Diet, High-Fat; Dietary Fats; Humans; Insulin; Insulin Resistance; Leptin; Male; Obesity; Overweight; Rats, Wistar | 2012 |
Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats.
Topics: Adiponectin; Adipose Tissue; Animals; Biological Products; Blood Glucose; Chitosan; Cholesterol; Diabetes Mellitus, Experimental; Glucagon-Like Peptide 1; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Liver; Male; PPAR alpha; Rats; Rats, Sprague-Dawley; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |